SNPS SEC Filings - Synopsys, Inc.- Annual Report, Proxy Statement, Prospectus

Basic Stats

LEI	QG7T915N9S0NY5UKNE63
CIK	883241

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Synopsys, Inc.

SEC Filings (Chronological Order)

This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.

July 23, 2025	EX-99.2	FIFTH AMENDED AND RESTATED ANSYS, INC. 1996 STOCK OPTION AND GRANT PLAN Exhibit 99.2 FIFTH AMENDED AND RESTATED ANSYS, INC. 1996 STOCK OPTION AND GRANT PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Fifth Amended and Restated ANSYS, Inc. 1996 Stock Option and Grant Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, consultants and key persons of ANSYS, Inc. (the “Company”) and
July 23, 2025	S-8	As filed with the Securities and Exchange Commission on July 23, 2025 As filed with the Securities and Exchange Commission on July 23, 2025 Registration No.
July 23, 2025	EX-99.3	FOURTH AMENDED AND RESTATED ANSYS, INC. 1996 STOCK OPTION AND GRANT PLAN Exhibit 99.3 FOURTH AMENDED AND RESTATED ANSYS, INC. 1996 STOCK OPTION AND GRANT PLAN SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the Fourth Amended and Restated ANSYS, Inc. 1996 Stock Option and Grant Plan (the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, consultants and key persons of ANSYS, Inc. (the “Company”) a
July 23, 2025	EX-99.1	ANSYS, INC. 2021 EQUITY AND INCENTIVE COMPENSATION PLAN Exhibit 99.1 ANSYS, INC. 2021 EQUITY AND INCENTIVE COMPENSATION PLAN 1. Purpose. The purpose of this Plan is to permit award grants to non-employee Directors, officers and other employees of the Company and its Subsidiaries, and certain Consultants to the Company and its Subsidiaries, and to provide to such persons incentives and rewards for service and/or performance. 2. Definitions. Except as ot
July 23, 2025	EX-FILING FEES	Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities EXHIBIT 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1)(2) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value of
July 17, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
July 17, 2025	EX-99.1	Synopsys Completes Acquisition of Ansys Creating the Leader in Engineering Solutions from Silicon to Systems Exhibit 99.1 Synopsys Completes Acquisition of Ansys Creating the Leader in Engineering Solutions from Silicon to Systems News Highlights: • Combines leaders in silicon design, IP and simulation and analysis to enable customers to rapidly innovate AI-powered products • Now positioned to win in an expanded $31 billion total addressable market (TAM)1 • Fast-tracking integrated technology roadmap, wi
July 17, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
July 17, 2025	EX-1.1	AMENDMENT TO AGREEMENT AND PLAN OF MERGER Exhibit 1.1 AMENDMENT TO AGREEMENT AND PLAN OF MERGER THIS AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made as of July 15, 2025, by and among ANSYS, Inc. (the “Company”), Synopsys, Inc. (“Parent”) and ALTA Acquisition Corp. (“Merger Sub”). Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Agreement and Plan of Merger, dated
July 17, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 ANSYS, Inc. (Exact UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 ANSYS, Inc. (Exact name of registrant as specified in its charter) Delaware 0-20853 04-3219960 (State or other jurisdiction of incorporation) (Commission File Number) (I
July 14, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 SYNOPSYS, INC. (Exa 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File N
July 14, 2025	EX-99.1	Synopsys Receives All Necessary Approvals for Proposed Acquisition of Ansys Exhibit 99.1 NEWS RELEASE Synopsys Receives All Necessary Approvals for Proposed Acquisition of Ansys SUNNYVALE, Calif., July 14, 2025 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has received approval from all necessary authorities to proceed with the acquisition of ANSYS, Inc. (Nasdaq: ANSS). The parties expect to close the transaction on or about Thursday, July 17, 2025, subject to t
July 14, 2025	425	Synopsys Receives All Necessary Approvals for Proposed Acquisition of Ansys Filed by Ansys, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934, as amended Subject Company: Ansys, Inc.; Synopsys, Inc. Commission File No.: 333-277912 NEWS RELEASE Synopsys Receives All Necessary Approvals for Proposed Acquisition of Ansys SUNNYVALE, Calif., July 14, 2025 – Synopsys, Inc. (N
July 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 SYNOPSYS, INC. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
July 3, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 2, 2025 SYNOPSYS, INC. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 2, 2025 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
June 30, 2025	425	Synopsys and Ansys Provide Update Regarding Expected Timing of Acquisition Close Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: June 30, 2025 NEWS RELEASE Synopsys and Ansys Provide Update Regarding Expected Timing of Acquisition Close SUNNYVALE, Calif. and PITTSBURGH, June 30,
June 30, 2025	425	Filed by Ansys, Inc. 425 Filed by Ansys, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934, as amended Subject Company: Ansys, Inc.; Synopsys, Inc. Commission File No.: 333-277912 Synopsys and Ansys Provide Update Regarding Expected Timing of Acquisition Close PITTSBURGH, PA, and SUNNYVALE, Calif., June 30, 2025 – S
May 30, 2025	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporatio SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 675 Almanor Ave Sunnyvale, California 94085 (Address of principal executive office
May 30, 2025	EX-1.01	Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2024 Exhibit 1.01 Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2024 Synopsys, Inc. (referred to as Synopsys, we, us, and our in this report) has submitted this Conflict Minerals Report for the year ended December 31, 2024 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (Rule 13p-1). Rule 13p-1 was adopted by the Securities and Exchange
May 29, 2025	8-K	Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 29, 2025 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 28, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
May 28, 2025	EX-FILING FEES	Filing Fee Exhibit EXHIBIT 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1)(2) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value
May 28, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 28, 2025 SYNOPSYS, INC. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 28, 2025 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 28, 2025	S-8	As filed with the Securities and Exchange Commission on May 28, 2025 As filed with the Securities and Exchange Commission on May 28, 2025 Registration No.
May 28, 2025	EX-99.1	Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025 Results Summary • Quarterly revenue of $1.604 billion, exceeding midpoint of guidance. • Quarterly GAAP earnings per diluted share of $2.24
April 11, 2025	EX-10.2	Employee Stock Purchase Plan, as amended EXHIBIT 10.2 SYNOPSYS, INC. EMPLOYEE STOCK PURCHASE PLAN (As amended by approval of the Board of Directors on January 24, 2025 and approved by the stockholders on April 10, 2025) I. PURPOSE The Synopsys, Inc. Employee Stock Purchase Plan (the “Plan”) is intended to provide Eligible Employees of the Company and one or more of its Corporate Affiliates with the opportunity to acquire a proprietary in
April 11, 2025	EX-10.1	2006 Employee Equity Incentive Plan, as amended EXHIBIT 10.1 SYNOPSYS, INC. 2006 EMPLOYEE EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 3, 2006 APPROVED BY THE STOCKHOLDERS: APRIL 25, 2006 AS AMENDED BY THE BOARD OF DIRECTORS: JANUARY 24, 2025 AMENDMENT APPROVED BY THE STOCKHOLDERS: APRIL 10, 2025 1. GENERAL. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employees and Consultants. Non-Employee Direct
April 11, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 10, 2025 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
March 17, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 SYNOPSYS, INC (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 SYNOPSYS, INC (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
March 17, 2025	EX-4.2	FIRST SUPPLEMENTAL INDENTURE Exhibit 4.2  FIRST SUPPLEMENTAL INDENTURE   THIS FIRST SUPPLEMENTAL INDENTURE, dated as of March 17, 2025 (this “Supplemental Indenture”), is between SYNOPSYS, INC., a Delaware corporation (the “Company”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as trustee for the 2027 Notes defined below (in such capacity, the “2027 Trustee”), the 2028 Notes defined below (in such capacity, the “2028 T
March 17, 2025	EX-4.1	Synopsys, Inc. Dated as of March 17, 2025 U.S. Bank Trust Company, National Association Exhibit 4.1 Synopsys, Inc. INDENTURE Dated as of March 17, 2025 U.S. Bank Trust Company, National Association Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 3 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction. 4 ARTICLE II THE SECURITIES 4 Section 2.1 Issua
March 5, 2025	EX-FILING FEES	Calculation of Filing Fee Tables (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Exhibit 107.1 Calculation of Filing Fee Tables 424(b)(5) (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(1) Carry Forward Form Type Carry Forward File Number Carry F
March 5, 2025	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
March 5, 2025	EX-1.1	SYNOPSYS, INC. (a Delaware corporation) $1,000,000,000 4.550% Senior Notes due 2027 $1,000,000,000 4.650% Senior Notes due 2028 $2,000,000,000 4.850% Senior Notes due 2030 $1,500,000,000 5.000% Senior Notes due 2032 $2,400,000,000 5.150% Senior Notes Exhibit 1.1 SYNOPSYS, INC. (a Delaware corporation) $1,000,000,000 4.550% Senior Notes due 2027 $1,000,000,000 4.650% Senior Notes due 2028 $2,000,000,000 4.850% Senior Notes due 2030 $1,500,000,000 5.000% Senior Notes due 2032 $2,400,000,000 5.150% Senior Notes due 2035 $2,100,000,000 5.700% Senior Notes due 2055 UNDERWRITING AGREEMENT Dated: March 3, 2025 SYNOPSYS, INC. (a Delaware corporation)
March 5, 2025	425	Synopsys Responds to U.K. Competition and Markets Authority’s Phase 1 Announcement Regarding Ansys Acquisition Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: March 5, 2025 Synopsys Responds to U.K. Competition and Markets Authority’s Phase 1 Announcement Regarding Ansys Acquisition SUNNYVALE, Calif., March
March 5, 2025	424B5	SYNOPSYS, INC. $1,000,000,000 4.550% Senior Notes due 2027 $1,000,000,000 4.650% Senior Notes due 2028 $2,000,000,000 4.850% Senior Notes due 2030 $1,500,000,000 5.000% Senior Notes due 2032 $2,400,000,000 5.150% Senior Notes due 2035 $2,100,000,000 TABLE OF CONTENTS Filed pursuant to Rule 424(b)(5) Registration No. 333-285378 PROSPECTUS SUPPLEMENT (To Prospectus dated February 27, 2025) $10,000,000,000 SYNOPSYS, INC. $1,000,000,000 4.550% Senior Notes due 2027 $1,000,000,000 4.650% Senior Notes due 2028 $2,000,000,000 4.850% Senior Notes due 2030 $1,500,000,000 5.000% Senior Notes due 2032 $2,400,000,000 5.150% Senior Notes due 2035 $2,100
March 3, 2025	424B5	Subject to Completion Preliminary Prospectus Supplement dated March 3, 2025 TABLE OF CONTENTS The information in this preliminary prospectus supplement is not complete and may be changed.
March 3, 2025	FWP	SYNOPSYS, INC. PRICING TERM SHEET March 3, 2025 $1,000,000,000 4.550% Senior Notes Due 2027 (the “2027 Notes”) $1,000,000,000 4.650% Senior Notes Due 2028 (the “2028 Notes”) $2,000,000,000 4.850% Senior Notes Due 2030 (the “2030 Notes”) $1,500,000,00 Filed Pursuant to Rule 433 Registration Statement No. 333-285378 Dated March 3, 2025 SYNOPSYS, INC. PRICING TERM SHEET March 3, 2025 $1,000,000,000 4.550% Senior Notes Due 2027 (the “2027 Notes”) $1,000,000,000 4.650% Senior Notes Due 2028 (the “2028 Notes”) $2,000,000,000 4.850% Senior Notes Due 2030 (the “2030 Notes”) $1,500,000,000 5.000% Senior Notes Due 2032 (the “2032 Notes”) $2,400,000,000
February 27, 2025	EX-FILING FEES	Calculation of Filing Fee Tables Form S-3 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Exhibit 107.1 Calculation of Filing Fee Tables Form S-3 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration
February 27, 2025	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File N
February 27, 2025	EX-99.1	ANSYS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Exhibit 99.1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Directors of ANSYS, Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of ANSYS, Inc. and subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, stockholders’ equity,
February 27, 2025	EX-99.2	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information presents the pro forma effects of the acquisition of Ansys by Synopsys along with effects of other related transactions described below. Ansys Acquisition On January 15, 2024, Synopsys, ALTA Acquisition Corp., a Delaware corporation and a wholly owned
February 27, 2025	EX-25.1	securities and exchange commission Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Exhibit 25.1 securities and exchange commission Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ☐ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E
February 27, 2025	EX-4.1	Synopsys, Inc. Dated as of ___________, 20___ U.S. Bank Trust Company, National Association TABLE OF CONTENTS Exhibit 4.1 Synopsys, Inc. INDENTURE Dated as of , 20 U.S. Bank Trust Company, National Association Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 3 Section 1.3 Incorporation by Reference of Trust Indenture Act 4 Section 1.4 Rules of Construction. 4 ARTICLE II THE SECURITIES 4 Section 2.1 Issuable in Ser
February 27, 2025	EX-99.2	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information presents the pro forma effects of the acquisition of Ansys by Synopsys along with effects of other related transactions described below. Ansys Acquisition On January 15, 2024, Synopsys, ALTA Acquisition Corp., a Delaware corporation and a wholly owned
February 27, 2025	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File N
February 27, 2025	S-3ASR	As filed with the Securities and Exchange Commission on February 27, 2025 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on February 27, 2025 Registration No.
February 27, 2025	EX-99.1	ANSYS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Exhibit 99.1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Directors of ANSYS, Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of ANSYS, Inc. and subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, stockholders’ equity,
February 26, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSY
February 26, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 26, 2025 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 26, 2025	EX-99.1	Synopsys Posts Financial Results for First Quarter Fiscal Year 2025 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for First Quarter Fiscal Year 2025 Results Summary • Quarterly revenue of $1.455 billion, exceeding midpoint of guidance. • Quarterly GAAP earnings per diluted share of $1.89;
February 14, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
February 14, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
January 10, 2025	425	Synopsys Responds to the European Commission Approving its Proposed Acquisition of Ansys in Phase 1 Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: January 10, 2025 Synopsys Responds to the European Commission Approving its Proposed Acquisition of Ansys in Phase 1 SUNNYVALE, Calif., January 10, 20
January 8, 2025	425	Synopsys Responds to the UK Competition and Markets Authority Provisionally Accepting its Proposed Remedies in Phase 1 Regarding its Proposed Acquisition of Ansys Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: January 8, 2025 Synopsys Responds to the UK Competition and Markets Authority Provisionally Accepting its Proposed Remedies in Phase 1 Regarding its P
January 6, 2025	425	Filed by Synopsys, Inc. Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: January 6, 2025 Ansys and Synopsys Announce Agreement with Keysight Technologies for Sale of Ansys PowerArtist / Key Highlights • Ansys PowerArtist is
December 20, 2024	425	Synopsys Responds to U.K. Competition and Markets Authority’s Phase 1 Announcement Regarding Ansys Acquisition Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 333-277912) Date: December 20, 2024 Synopsys Responds to U.K. Competition and Markets Authority’s Phase 1 Announcement Regarding Ansys Acquisition SUNNYVALE, Calif., De
December 19, 2024	EX-21.1	Subsidiaries of Synopsys, Inc. EXHIBIT 21.1 SUBSIDIARIES OF SYNOPSYS, INC.* Name Jurisdiction of Incorporation Nihon Synopsys G.K. Japan PikeTec GmbH Germany SNPS Ireland New Limited Ireland Synopsys (India) Private Limited India Synopsys Emulation and Verification SAS France Synopsys International Limited Ireland Synopsys International Services, Inc. Delaware Synopsys Korea, Inc. Korea Synopsys Software Science and Technology
December 19, 2024	EX-19.1	Trading Policy Exhibit 19.1 Certain information contained in this document has been redacted pursuant to Item 601(a)(6) of Regulation S-K. Redacted information is indicated with the notation “[***]”. INSIDER TRADING POLICY 1. PURPOSE This Insider Trading Policy (the “Policy”) establishes rules and procedures designed to prevent Covered Persons (as defined below) from trading, or causing the trading of, or engagi
December 19, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19807
December 4, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 4, 2024 SYNOPSYS, INC. ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 4, 2024 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number
December 4, 2024	EX-99.1	Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024 Results Summary1 • Record quarterly revenue of $1.636 billion, up approximately 11% year over year (YoY), exceeding the mid-point of gu
November 25, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 25, 2024 SYNOPSYS, INC. (Exact name of registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
October 1, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File
September 19, 2024	425	Synopsys Enters Definitive Agreement with Keysight Technologies For Sale of Optical Solutions Group Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 000-20853) NEWS RELEASE Synopsys Enters Definitive Agreement with Keysight Technologies For Sale of Optical Solutions Group Highlights: ● Synopsys to sell its Optical S
August 23, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JULY 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
August 21, 2024	EX-99.1	Synopsys Posts Financial Results for Third Quarter Fiscal Year 2024 EX-99.1 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Third Quarter Fiscal Year 2024 Results Summary1 • Record quarterly revenue of $1.526 billion, up approximately 13% year over year. • Quarterly GAAP earnings per di
August 21, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 21, 2024 SYNOPSYS, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 21, 2024 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
July 12, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2024 (July 10, 2024) SYN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2024 (July 10, 2024) SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commi
May 30, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 (State or other jurisdiction of incorporation) (Commiss UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 (State or other jurisdiction of incorporation) (Commission File Number) 675 Almanor Ave. Sunnyvale, California 94085 (Address of principal executive offices) John F. Runkel, Jr. General Counsel and Corpora
May 30, 2024	EX-1.01	Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2023 Exhibit 1.01 Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2023 Synopsys, Inc. (referred to as “Synopsys,” “we,” “us,” and “our” in this report) has submitted this Conflict Minerals Report for the year ended December 31, 2023 in order to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (Rule 13p-1). Rule 13p-1 was adopted by the Securities and
May 24, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
May 24, 2024	EX-FILING FEES	Filing Fee Exhibit EXHIBIT 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value of $0.01
May 24, 2024	S-8	Power of Attorney (included in signature page) As filed with the Securities and Exchange Commission on May 24, 2024 Registration No.
May 22, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 22, 2024 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 22, 2024	EX-99.1	Synopsys Posts Financial Results for Second Quarter Fiscal Year 2024 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Second Quarter Fiscal Year 2024 Results Summary1 • Quarterly revenue of $1.455 billion, up approximately 15% year over year and at the high-end of guidance. • Quarterly GA
May 16, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 SYNOPSYS, INC. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Number
May 16, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 SYNOPSYS, INC. (Exac Filed by Synopsys, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. Commission File No.: 000-2853 Date: May 16, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the S
May 16, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2024 (May 14, 2024) ANSYS, Filed by Ansys, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934, as amended Subject Company: Ansys, Inc.; Synopsys, Inc. Commission File No.: 333-277912 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securiti
May 13, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2024 ANSYS, Inc. (Exact nam Filed by Ansys, Inc. Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934, as amended Subject Company: Ansys, Inc.; Synopsys, Inc. Commission File No.: 333-277912 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securiti
May 6, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2024 SYNOPSYS, INC. (Exact UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 6, 2024	EX-99.1	Synopsys Enters Definitive Agreement to Sell its Software Integrity Business to Clearlake Capital and Francisco Partners EX-99.1 EXHIBIT 99.1 NEWS RELEASE Synopsys Enters Definitive Agreement to Sell its Software Integrity Business to Clearlake Capital and Francisco Partners Highlights: • Transaction will establish the Software Integrity Group as a newly independent, leading application security testing software provider. • The transaction, valued at up to $2.1 billion, is expected to close in the second half of 202
April 17, 2024	424B3	MERGER PROPOSAL—YOUR VOTE IS VERY IMPORTANT TABLE OF CONTENTS Filed pursuant to Rule 424(b)(3) Registration No. 333-277912 MERGER PROPOSAL—YOUR VOTE IS VERY IMPORTANT Dear ANSYS, Inc. Stockholder: You are cordially invited to attend a special meeting of stockholders of ANSYS, Inc., a Delaware corporation, which is referred to as “Ansys,” to be held on May 22, 2024, virtually via the Internet at www.virtualshareholdermeeting.com/ANSS2024
April 12, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 10, 2024 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
April 12, 2024	EX-10.1	2006 Employee Equity Incentive Plan, as amended EXHIBIT 10.1 SYNOPSYS, INC. 2006 EMPLOYEE EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 3, 2006 APPROVED BY THE STOCKHOLDERS: APRIL 25, 2006 AS AMENDED BY THE BOARD OF DIRECTORS: JANUARY 19, 2024 AMENDMENT APPROVED BY THE STOCKHOLDERS: APRIL 10, 2024 1. GENERAL. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employees and Consultants. Non-Employee Direct
April 11, 2024	EX-99.2	EX-99.2 Exhibit 99.2
April 11, 2024	EX-99.1	Consent of Qatalyst Partners LP Exhibit 99.1 Consent of Qatalyst Partners LP April 11, 2024 We hereby consent to the use in the proxy statement/prospectus pursuant to Section 14(a) of the Securities Exchange Act of 1934 that forms part of the Registration Statement on Form S-4 of Synopsys, Inc. (the “Proxy Statement”) of our opinion dated January 15, 2024 appearing as Annex B to such Proxy Statement, and to the description of su
April 11, 2024	CORRESP	Synopsys, Inc. 675 Almanor Ave. Sunnyvale, California 94085 Synopsys, Inc. 675 Almanor Ave. Sunnyvale, California 94085 April 11, 2024 VIA EDGAR Office of Technology Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Lauren Pierce Matthew Derby Re: Synopsys, Inc. Registration Statement on Form S-4, as amended File No. 333-277912 (the “Registration Statement”) Ladies and Gentlemen: Pursuant
April 11, 2024	S-4/A	As filed with the U.S. Securities and Exchange Commission on April 11, 2024 TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on April 11, 2024 Registration No. 333-277912 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYNOPSYS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 7372 56-1546236 (State of Incorporation) (P
March 25, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
March 25, 2024	EX-3.1	Amended and Restated Bylaws EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF SYNOPSYS, INC. (as amended and restated on March 25, 2024) ARTICLE I OFFICES Section 1. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 2. The corporation may also have offices at such other places both within and without the State of Delaware as the Board of Directors of the corporation (the “Boa
March 25, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 25, 2024 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
March 20, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2024 SYNOPSYS, INC. (Ex 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File
March 20, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2024 SYNOPSYS, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numb
March 20, 2024	EX-99.1	Synopsys Cautionary Statement Regarding Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Synopsys and Ansys, in Exhibit 99.1 © 2024 Synopsys, Inc. 1 Synopsys Cautionary Statement Regarding Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Synopsys and Ansys, including, but not limited to, statements regarding the proposed transaction; the anticipated market demand and out
March 19, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2024 SYNOPSYS, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Numb
March 19, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2024 SYNOPSYS, INC. (Ex 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File
March 14, 2024	S-4	As filed with the U.S. Securities and Exchange Commission on March 13, 2024 TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on March 13, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYNOPSYS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 7372 56-1546236 (State of Incorporation) (Primary Standard Indust
March 14, 2024	EX-99.1	Consent of Qatalyst Partners LP Exhibit 99.1 Consent of Qatalyst Partners LP March 13, 2024 We hereby consent to the use in the proxy statement/prospectus pursuant to Section 14(a) of the Securities Exchange Act of 1934 that forms part of the Registration Statement on Form S-4 of Synopsys, Inc. (the “Proxy Statement”) of our opinion dated January 15, 2024 appearing as Annex B to such Proxy Statement, and to the description of su
March 14, 2024	EX-FILING FEES	Calculation of Filing Fee Tables Form S-4 (Form Type) Synopsys, Inc. (Exact Name of Registrant Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Exhibit 107 Calculation of Filing Fee Tables Form S-4 (Form Type) Synopsys, Inc. (Exact Name of Registrant Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title(1) Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Fo
March 14, 2024	EX-21.1	SUBSIDIARIES OF SYNOPSYS, INC.* EXHIBIT 21.1 SUBSIDIARIES OF SYNOPSYS, INC.* Name Jurisdiction of Incorporation Black Duck Software, Inc. Delaware Nihon Synopsys G.K. Japan PikeTec GmbH Germany SNPS Ireland New Limited Ireland Synopsys (India) Private Limited India Synopsys Emulation and Verification SAS France Synopsys International Limited Ireland Synopsys International Services, Inc. Delaware Synopsys Korea, Inc. Korea Synops
February 23, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSY
February 21, 2024	EX-99.1	Synopsys Posts Financial Results for First Quarter Fiscal Year 2024 EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for First Quarter Fiscal Year 2024 Results Summary • Record quarterly revenue of $1.649 billion, up approximately 21% year over year. • Quarterly GAAP earnings per dil
February 21, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 21, 2024 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 21, 2024 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 16, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
February 16, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
February 14, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File N
February 14, 2024	EX-2.2	Term Loan Facility Credit Agreement, dated February 13, 2024, by and among Synopsys, as borrower, the lenders party thereto, HSBC Securities (USA) Inc., and Bank of America, N.A., as co-syndication agents, Mizuho Bank, LTD., The Bank of Nova Scotia, TD Bank, N.A., Truist Bank, and Wells Fargo Bank, National Association, as co-documentation agents, and JPMorgan Chase Bank, N.A., as administrative agent for the lenders. Exhibit 2.2 Execution Version $4,300,000,000 TERM LOAN FACILITY CREDIT AGREEMENT among SYNOPSYS, INC., as Borrower, The Several Lenders from Time to Time Parties Hereto, HSBC SECURITIES (USA) INC. and BANK OF AMERICA, N.A., as Co-Syndication Agents, MIZUHO BANK, LTD., THE BANK OF NOVA SCOTIA, TD BANK, N.A., TRUIST BANK and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Co-Documentation Agents, and JPM
February 14, 2024	EX-2.1	Sixth Amendment Agreement, dated February 13, 2024, by and among Synopsys, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders. Exhibit 2.1 Execution Version SIXTH AMENDMENT AGREEMENT dated as of February 13, 2024 (this “Sixth Amendment Agreement”), to the Credit Agreement, dated as of October 14, 2011, as amended and restated on February 17, 2012, on May 19, 2015, on November 28, 2016, on January 22, 2021 and on December 14, 2022 (as further amended, supplemented, restated or otherwise modified prior to the date hereof, t
February 13, 2024	SC 13G/A	SNPS / Synopsys, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv02029-synopsysinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Synopsys Inc Title of Class of Securities: Common Stock CUSIP Number: 871607107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule
January 17, 2024	425	The transcript that follows is of Synopsys, Inc.’s live video webcast with ANSYS, Inc. on January 16, 2024. Trey Campbell Synopsys, Inc. 8:30 am ET Operator: Good day, ladies and gentlemen, and welcome to the Synopsys Special Event Call. At this time 425 Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 000-20853) Date: January 16, 2024 The transcript that follows is of Synopsys, Inc.’s live video webcast with ANSYS, Inc. on January 16, 2024. SYNOPSYS Trey Campbell
January 16, 2024	EX-2.1	Agreement and Plan of Merger, dated as of January 15, 2024, by and among Synopsys, Inc., ANSYS, Inc. and ALTA Acquisition Corp. Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER by and among: SYNOPSYS, INC., a Delaware corporation; ALTA ACQUISITION CORP., a Delaware corporation; and ANSYS, INC., a Delaware corporation Dated as of January 15, 2024 TABLE OF CONTENTS Page SECTION 1. THE TRANSACTION 1 1.1 The Merger 1 1.2 Effects of the Merger 1 1.3 Closing; Effective Time 1 1.4 Certificate of Incorporation and Bylaws; D
January 16, 2024	425	Public FAQ for Microsite 425 Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 000-20853) Date: January 16, 2024 The following FAQ was made available on the transaction website, https://synopsysansys.transactionfacts.com/ on January 16, 2024:
January 16, 2024	425	Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 000-20853) Creatin 425 Filed by Synopsys, Inc. pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: ANSYS, Inc. (Commission File No. 000-20853) Creating a Leader in Silicon to Systems Design Solutions January 16, 2024 Ansys Fiscal Year 2023 Preliminary Results Ansys has not completed preparation
January 16, 2024	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2024 SYNOPSYS, INC. ( 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission Fil
January 16, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2024 SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 000-19807 56-1546236 (State or Other Jurisdiction of Incorporation) (Commission File Nu
January 16, 2024	EX-99.1	Synopsys to Acquire Ansys, Creating a Leader in Silicon to Systems Design Solutions Exhibit 99.1 Synopsys to Acquire Ansys, Creating a Leader in Silicon to Systems Design Solutions Highlights: • Combines Leaders in Semiconductor Design Technology and Simulation and Analysis to Address Customers’ Needs for Fusion of Electronics and Physics, Augmented with AI • Enhances and Accelerates Synopsys’ Silicon to Systems Strategy in Core EDA and New Attractive, Adjacent Growth Areas • Exp
December 21, 2023	EX-10.1	Employment Agreement, dated December 20, 2023 between Synopsys, Inc. and Mr. Sassine Ghazi EX-10.1 EXHIBIT 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made and entered into on December 20, 2023 (the “Execution Date”) by and between Sassine Ghazi (the “Employee”) and Synopsys, Inc., a Delaware corporation (the “Company”). This Agreement is effective as of January 1, 2024 (the “Effective Date”). R E C I T A L S A. The Employee is currently employed by the Comp
December 21, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 12, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 12, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commi
December 21, 2023	EX-10.2	Executive Chairperson Agreement, dated December 20, 2023 between Synopsys, Inc. and Dr. Aart J. de Geus EX-10.2 EXHIBIT 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made and entered into on December 20, 2023 (the “Execution Date”) by and between Aart de Geus (the “Employee”) and Synopsys, Inc., a Delaware corporation (the “Company”). This Agreement is effective as of January 1, 2024 (the “Effective Date”). R E C I T A L S A. The Employee is currently employed by the Compa
December 13, 2023	EX-3.1	Amended and Restated Bylaws EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF SYNOPSYS, INC. (as amended and restated on December 12, 2023) ARTICLE I OFFICES Section 1. The registered office shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 2. The corporation may also have offices at such other places both within and without the State of Delaware as the Board of Directors of the corporation (the “
December 13, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 12, 2023 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 12, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 12, 2023	EX-97.1	Compensation Recovery Policy Exhibit 97.1 SYNOPSYS, INC. Executive Officer Compensation Recovery Policy This Executive Officer Compensation Recovery Policy (the “Policy”) covers the Covered Officers of Synopsys, Inc. (the “Company”) and explains when the Company will be required to seek recovery of Incentive Compensation awarded or paid to Covered Officers. Refer to Exhibit A attached hereto (the “Definitions Exhibit”) for th
December 12, 2023	EX-21.1	Subsidiaries of Synopsys, Inc. EXHIBIT 21.1 SUBSIDIARIES OF SYNOPSYS, INC.* Name Jurisdiction of Incorporation Black Duck Software, Inc. Delaware Nihon Synopsys G.K. Japan PikeTec GmbH Germany SNPS Ireland New Limited Ireland Synopsys (India) Private Limited India Synopsys Emulation and Verification SAS France Synopsys International Limited Ireland Synopsys International Services, Inc. Delaware Synopsys Korea, Inc. Korea Synops
December 12, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19807
November 29, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 29, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
November 29, 2023	EX-99.1	Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023 Results Summary • Record quarterly revenue of $1.599 billion, up approximately 25% year over year. Record fiscal-year revenue of $5.843
September 1, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commis
August 24, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 24, 2023 SYNOPSYS, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 24, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 24, 2023	EX-99.1	Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement EX-99.1 EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement SUNNYVALE, Calif. – Aug. 24, 2023 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share re
August 18, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JULY 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
August 16, 2023	EX-99.1	Synopsys Posts Financial Results for Third Quarter Fiscal Year 2023 Announces Sassine Ghazi to Assume President and CEO Role Effective Jan. 1, 2024 EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Cara Walker Synopsys, Inc. 650-584-5000 [email protected] Synopsys Posts Financial Results for Third Quarter Fiscal Year 2023 Announces Sassine Ghazi to Assume President and CEO Role Effective Jan. 1, 2024 Q3 FY 2023 Summary • Record quarterly revenue of $1.
August 16, 2023	EX-99.1	Synopsys Announces Sassine Ghazi to Assume President and CEO Role Jan. 1, 2024 Aart de Geus to Take Role of Executive Chair at that Time EX-99.1 Exhibit 99.1 NEWS RELEASE Synopsys Announces Sassine Ghazi to Assume President and CEO Role Jan. 1, 2024 Aart de Geus to Take Role of Executive Chair at that Time Sunnyvale, Calif., Aug. 16, 2023 –Synopsys, Inc. (Nasdaq: SNPS) today announced that its Board of Directors has appointed Sassine Ghazi as president and Chief Executive Officer effective on Jan. 1, 2024. At that time, Aart de Geu
August 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 12, 2023 SYNOPSYS, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 12, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 16, 2023 SYNOPSYS, INC. (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 16, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 7, 2023	EX-99.1	Synopsys Appoints Rob Painter to Board of Directors EX-99.1 Exhibit 99.1 Synopsys Appoints Rob Painter to Board of Directors SUNNYVALE, Calif., Aug. 7, 2023 — Synopsys, Inc. (Nasdaq: SNPS) today announced the appointment of Rob Painter to its board of directors. Painter currently serves as president and chief executive officer at Trimble (Nasdaq: TRMB), a global technology company focused on transforming work for industries spanning agriculture, co
August 7, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2023 SYNOPSYS, INC. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 4, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
June 16, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 12, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 12, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commis
May 26, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 690 East Middlefield Road Mountain View, California 94043 (Address of principal execu
May 26, 2023	EX-1.01	Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. EX-1.01 Exhibit 1.01 Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2022 Synopsys, Inc. (referred to as “Synopsys,” “we,” “us,” and “our” in this report) has submitted this Conflict Minerals Report for the year ended December 31, 2022 in order to comply with Rule 13p-1 under the Securities Exchange Act, as amended. Rule 13p-1 was adopted by the Securities and Exchange Comm
May 25, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 25, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 25, 2023	EX-99.1	Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement EX-99.1 EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Jim Brady Synopsys, Inc. 408-482-4719 [email protected] Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – May 25, 2023 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share
May 19, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
May 19, 2023	EX-FILING FEES	Filing Fee Exhibit EXHIBIT 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value of $0.01
May 19, 2023	S-8	As filed with the Securities and Exchange Commission on May 19, 2023 S-8 As filed with the Securities and Exchange Commission on May 19, 2023 Registration No.
May 17, 2023	EX-99.1	Synopsys Posts Financial Results for Second Quarter Fiscal Year 2023 EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Trey Campbell Synopsys, Inc. 650-584-4289 [email protected] EDITORIAL CONTACT: Jim Brady Synopsys, Inc. 408-482-4719 [email protected] Synopsys Posts Financial Results for Second Quarter Fiscal Year 2023 Q2 FY 2023 Financial Highlights • Revenue: $1.395 billion • GAAP earnings per diluted share: $1.76 • Non-GAAP earnings per diluted
May 17, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2023 SYNOPSYS, INC. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 17, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
April 14, 2023	EX-10.3	Form of Restricted Stock Unit Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan EX-10.3 EXHIBIT 10.3 SYNOPSYS, INC. RESTRICTED STOCK UNIT GRANT NOTICE AND AWARD AGREEMENT (2006 EMPLOYEE EQUITY INCENTIVE PLAN) Synopsys, Inc. (the “Company”), pursuant to Section 7(b) of the Company’s 2006 Employee Equity Incentive Plan (the “Plan”), hereby awards to you as Participant a Restricted Stock Unit Award covering the number of restricted stock units (the “Restricted Stock Units”) set
April 14, 2023	EX-10.4	Form of Stock Option Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan EX-10.4 EXHIBIT 10.4 2006 Employee Equity Incentive Plan Notice of Grant of Stock Options and Option Agreement Synopsys, Inc. ID: 56-1546236 690 East Middlefield Road Mountain View, CA 94043 [INSERT NAME, ADDRESS] Option Number: ID: Effective , Synopsys, Inc. (the “Company”) has granted you a Nonstatutory Stock Option (the “Option”) under the 2006 Employee Equity Incentive Plan (the “Plan”) to buy
April 14, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 12, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
April 14, 2023	EX-10.2	2006 Employee Equity Incentive Plan, as amended EX-10.2 EXHIBIT 10.2 SYNOPSYS, INC. 2006 EMPLOYEE EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 3, 2006 APPROVED BY THE STOCKHOLDERS: APRIL 25, 2006 AS AMENDED BY THE BOARD OF DIRECTORS: JANUARY 19, 2023 AMENDMENT APPROVED BY THE STOCKHOLDERS: APRIL 12, 2023 TERMINATION DATE: APRIL 1, 2026 1. GENERAL. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employ
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2023 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 23, 2023	EX-99.1	Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement EX-99.1 EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Philip Lee Synopsys, Inc. 650-584-1080 [email protected] EDITORIAL CONTACT: Jim Brady Synopsys, Inc. 408-482-4719 [email protected] Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – Feb. 23, 2023 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share r
February 17, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin
February 17, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin
February 17, 2023	EX-10.1	Executive Incentive Plan, as amended Exhibit 10.1 SYNOPSYS, INC. EXECUTIVE INCENTIVE PLAN (amended and restated on January 19, 2023) I.PLAN OBJECTIVES: This Synopsys, Inc Executive Incentive Plan (the “Plan”) provides members of management of Synopsys, Inc. (the “Company”) the potential to earn variable compensation linked directly to: (i) driving the strategic direction of the Company, (ii) driving attainment of financial targets, a
February 17, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSY
February 15, 2023	EX-99.1	Synopsys Posts Financial Results for First Quarter Fiscal Year 2023 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Philip Lee Synopsys, Inc. 650-584-1080 [email protected] EDITORIAL CONTACT: Jim Brady Synopsys, Inc. 408-482-4719 [email protected] Synopsys Posts Financial Results for First Quarter Fiscal Year 2023 Q1 FY 2023 Financial Highlights • Revenue: $1.361 billion • GAAP earnings per diluted share: $1.75 • Non-GAAP earnings per diluted share: $2.62
February 15, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 15, 2023 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 9, 2023	SC 13G/A	SNPS / Synopsys, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Synopsys Inc. Title of Class of Securities: Common Stock CUSIP Number: 871607107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
December 16, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 16, 2022 SYNOPSYS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 16, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 16, 2022	EX-99.1	Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement EX-99.1 EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $300 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – Dec. 16, 2022 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated sha
December 14, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 14, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 14, 2022	EX-10.1	Fifth Extension and Amendment Agreement, dated December 14, 2022, among Synopsys as Borrower, the Lenders parties thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders. EXHIBIT 10.1 FIFTH EXTENSION AND AMENDMENT AGREEMENT dated as of December 14, 2022 (this ?Fifth Extension and Amendment Agreement?), to the Credit Agreement, dated as of October 14, 2011, as amended and restated on February 17, 2012, on May 19, 2015, on November 28, 2016 and on January 22, 2021 (as further amended, supplemented, restated or otherwise modified prior to the date hereof, the ?Existin
December 12, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19807
December 12, 2022	EX-21.1	Subsidiaries of Synopsys, Inc. EXHIBIT 21.1 SUBSIDIARIES OF SYNOPSYS, INC.* Name Jurisdiction of Incorporation SNPS Ireland New Limited Ireland Synopsys International Limited Ireland Synopsys International Services, Inc. Delaware Synopsys USIE Holdings LLC Delaware Black Duck Software, Inc. Delaware Nihon Synopsys G.K. Japan Synopsys (India) Private Limited India Synopsys Emulation and Verification S.A.S. France Synopsys Korea,
November 30, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 30, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
November 30, 2022	EX-99.1	Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2022 EX-99.1 2 d425134dex991.htm EX-99.1 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2022 Q4 FY 2022 Financial Highlights • Revenue: $1.284 billion • GAAP earnings per diluted share: $0.99
November 29, 2022	EX-10.1	Offer Letter, dated November 23, 2022, by and between Synopsys, Inc. and Shelagh Glaser Exhibit 10.1 Synopsys Inc. 690 East Middlefield Road Mountain View, CA 94043-4010 T. 650.584.5000 www.synopsys.com VIA E-MAIL November 22, 2022 Dear Shelagh, I am pleased to offer you the position of Chief Financial Officer (?CFO?) of Synopsys, Inc. (?Synopsys? or the ?Company?). This is a regular full-time exempt position reporting to Aart de Geus, Chairman and Chief Executive Officer. As CFO, yo
November 29, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 28, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
November 29, 2022	EX-99.1	Synopsys Appoints Shelagh Glaser Chief Financial Officer Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Appoints Shelagh Glaser Chief Financial Officer MOUNTAIN VIEW, Calif. ? Nov. 29, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that it has appointed Shelagh Glaser as chief financial officer,
October 13, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 13, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number
September 1, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 1, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
September 1, 2022	EX-99.1	Synopsys Approves Stock Repurchase Program with Authorization Up to $1.5 Billion EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Approves Stock Repurchase Program with Authorization Up to $1.5 Billion MOUNTAIN VIEW, Calif. ? Sep. 1, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that its Board of Directors has replenishe
August 25, 2022	EX-99.1	Synopsys Initiates $240 Million Accelerated Share Repurchase Agreement EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $240 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. ? August 25, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share rep
August 25, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 25, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 19, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JULY 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
August 17, 2022	EX-99.1	Synopsys Posts Financial Results for Third Quarter Fiscal Year 2022 EXHIBIT 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Third Quarter Fiscal Year 2022 Q3 FY 2022 Financial Highlights ? Revenue: $1.248 billion ? GAAP earnings per diluted share: $1.43 ? Non-GAAP earnings per diluted share: $
August 17, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 17, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
May 31, 2022	EX-1.01	Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2021 EX-1.01 2 d256491dex101.htm EX-1.01 Exhibit 1.01 Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2021 Synopsys, Inc. (referred to as “Synopsys,” “we,” “us,” and “our” in this report) has submitted this Conflict Minerals Report for the year ended December 31, 2021 in order to comply with Rule 13p-1 under the Securities Exchange Act, as amended. Rule 13p-1 was adopted by the
May 31, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporatio SD 1 d256491dsd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 690 East Middlefield Road Mountain View, California 94043 (Add
May 27, 2022	EX-99.1	Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement EXHIBIT 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. ? May 27, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share repurc
May 27, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 27, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 25, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 23, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 25, 2022	EX-99.1	Synopsys Appoints Two New Directors Exhibit 99.1 Editorial Contact: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Investor Contact: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] Synopsys Appoints Two New Directors MOUNTAIN VIEW, Calif., May 25, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced the appointment of Luis Borgen and Marc Casper to its board of directors. Borgen most recently served
May 20, 2022	EX-FILING FEES	Filing Fee Exhibit EX-FILING FEES 4 d353612dexfilingfees.htm EX-FILING FEES Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Synopsys, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of
May 20, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
May 20, 2022	S-8	As filed with the Securities and Exchange Commission on May 20, 2022 As filed with the Securities and Exchange Commission on May 20, 2022 Registration No.
May 19, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 13, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 18, 2022	EX-99.1	Synopsys Posts Financial Results for Second Quarter Fiscal Year 2022 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Second Quarter Fiscal Year 2022 Q2 FY 2022 Financial Highlights ? Revenue: $1.279 billion ? GAAP earnings per diluted share: $1.89 ? Non-GAAP earnings per diluted share:
May 18, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 18, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
April 15, 2022	EX-10.3	2006 Employee Equity Incentive Plan, as amended EXHIBIT 10.3 SYNOPSYS, INC. 2006 EMPLOYEE EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 3, 2006 APPROVED BY THE STOCKHOLDERS: APRIL 25, 2006 AS AMENDED BY THE BOARD OF DIRECTORS: JANUARY 19, 2022 AMENDMENT APPROVED BY THE STOCKHOLDERS: APRIL 12, 2022 TERMINATION DATE: APRIL 1, 2026 1. GENERAL. (a) Eligible Award Recipients. The persons eligible to receive Awards are Employees and
April 15, 2022	EX-10.4	Form of Restricted Stock Unit Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan EXHIBIT 10.4 SYNOPSYS, INC. RESTRICTED STOCK UNIT GRANT NOTICE AND AWARD AGREEMENT (2006 EMPLOYEE EQUITY INCENTIVE PLAN) Synopsys, Inc. (the ?Company?), pursuant to Section 7(b) of the Company?s 2006 Employee Equity Incentive Plan (the ?Plan?), hereby awards to you as Participant a Restricted Stock Unit Award covering the number of restricted stock units (the ?Restricted Stock Units?) set forth be
April 15, 2022	EX-10.6	Employee Stock Purchase Plan, as amended EXHIBIT 10.6 SYNOPSYS, INC. EMPLOYEE STOCK PURCHASE PLAN (As amended by approval of the Board of Directors on January 19, 2022 and approved by the stockholders on April 12, 2022) I. PURPOSE The Synopsys, Inc. Employee Stock Purchase Plan (the ?Plan?) is intended to provide Eligible Employees of the Company and one or more of its Corporate Affiliates with the opportunity to acquire a proprietary in
April 15, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 12, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
April 15, 2022	EX-10.5	Form of Stock Option Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan EXHIBIT 10.5 2006 Employee Equity Incentive Plan Notice of Grant of Stock Options and Option Agreement Synopsys, Inc. ID: 56-1546236 690 East Middlefield Road Mountain View, CA 94043 %%FIRSTNAME%-%LASTNAME%-% %%ADDRESSLINE1%-% %%ADDRESSLINE2%-% %%CITY%-%STATE%-%ZIPCODE%-% %%COUNTRY%-% Option Number: %%OPTIONNUMBER%-% ID: %%EMPLOYEEIDENTIFIER%-% Effective %%OPTIONDATE%-%, Synopsys, Inc. (the ?Compa
February 25, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 25, 2022	EX-99.1	Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement Exhibit 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. ? Feb. 25, 2022 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share repur
February 23, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A 1 a2022proxystatementdef14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission
February 23, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEFA14A 1 a2022proxystatement-addlma.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commissio
February 18, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSY
February 18, 2022	EX-10.3	Form of Stock Option Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan Exhibit 10.3 2006 Employee Equity Incentive Plan Notice of Grant of Stock Options and Option Agreement Synopsys, Inc. ID: 56-1546236 690 East Middlefield Road Mountain View, CA 94043 %%FIRSTNAME%-%LASTNAME%-% %%ADDRESSLINE1%-% %%ADDRESSLINE2%-% %%CITY%-%STATE%-%ZIPCODE%-% %%COUNTRY%-% Option Number: %%OPTIONNUMBER%-% ID: %%EMPLOYEEIDENTIFIER%-% Effective %%OPTIONDATE%-%, Synopsys, Inc. (the ?Compa
February 18, 2022	EX-10.2	Form of Restricted Stock Unit Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan Exhibit 10.2 Synopsys, Inc. Restricted Stock Unit Grant Notice and Award Agreement (2006 Employee Equity Incentive Plan) Synopsys, Inc. (the ?Company?), pursuant to Section 7(b) of the Company?s 2006 Employee Equity Incentive Plan (the ?Plan?), hereby awards to you as Participant a Restricted Stock Unit Award covering the number of restricted stock units (the ?Restricted Stock Units?) set forth be
February 16, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 16, 2022 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 16, 2022	EX-99.1	Synopsys Posts Financial Results for First Quarter Fiscal Year 2022 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for First Quarter Fiscal Year 2022 Q1 FY 2022 Financial Highlights ? Revenue: $1.270 billion ? GAAP earnings per diluted share: $1.99 ? Non-GAAP earnings per diluted share: $
February 10, 2022	SC 13G/A	SNPS / Synopsys, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Synopsys Inc. Title of Class of Securities: Common Stock CUSIP Number: 871607107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
December 16, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 16, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 16, 2021	EX-99.1	Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement EX-99.1 2 d170125dex991.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $200 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – Dec. 16, 2021 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has ent
December 13, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended October 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19807
December 13, 2021	EX-21.1	Subsidiaries of Synopsys, Inc. EXHIBIT 21.1 SUBSIDIARIES OF SYNOPSYS, INC.* Name Jurisdiction of Incorporation Synopsys International Limited Ireland SNPS Ireland New Limited Ireland Synopsys USIE Holdings LLC Delaware Synopsys International Services, Inc. Delaware Black Duck Software, Inc. Delaware Synopsys Taiwan Co., Ltd. Taiwan Nihon Synopsys G.K. Japan Synopsys Emulation and Verification S.A.S. France Synopsys (India) Priv
December 10, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 10, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 10, 2021	EX-99.1	Synopsys Approves Stock Repurchase Program with Authorization Up to $1 Billion EX-99.1 2 d239575dex991.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Approves Stock Repurchase Program with Authorization Up to $1 Billion MOUNTAIN VIEW, Calif. – Dec. 10, 2021 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it
December 6, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 3, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number
December 6, 2021	EX-10.1	Executive Incentive Plan, as amended and restated on December 3, 2021 EX-10.1 2 d183482dex101.htm EX-10.1 Exhibit 10.1 SYNOPSYS, INC. EXECUTIVE INCENTIVE PLAN (amended and restated on December 3, 2021) I. PLAN OBJECTIVES: This Synopsys, Inc Executive Incentive Plan (the “Plan”) provides members of management of Synopsys, Inc. (the “Company”) the potential to earn variable compensation linked directly to: (i) driving the strategic direction of the Company, (ii) drivi
December 1, 2021	EX-99.1	Synopsys Announces Planned Retirement of CFO Trac Pham Exhibit 99.1 NEWS RELEASE Editorial Contact: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Investor Contact: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] Synopsys Announces Planned Retirement of CFO Trac Pham MOUNTAIN VIEW, Calif., Dec. 1, 2021 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that Trac Pham, chief financial officer, intends to retire in 2022. T
December 1, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 28, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
December 1, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 1, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number
December 1, 2021	EX-99.1	Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2021 EX-99.1 2 d123849dex991.htm EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2021 Q4 FY 2021 Financial Highlights • Revenue: $1.152 billion • GAAP earnings per share: $1.28 • Non-G
September 13, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 13, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numb
September 13, 2021	EX-99.1	Synopsys Appoints Sassine Ghazi as President and Chief Operating Officer; Chi-Foon Chan to Transition from co-CEO Role EX-99.1 2 d180682dex991.htm EX-99.1 Exhibit 99.1 NEWS RELEASE Editorial Contact: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Investor Contact: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] Synopsys Appoints Sassine Ghazi as President and Chief Operating Officer; Chi-Foon Chan to Transition from co-CEO Role MOUNTAIN VIEW, Calif., September 13, 2021 – Synopsys,
August 26, 2021	EX-99.1	Synopsys Initiates $175 Million Accelerated Share Repurchase Agreement EX-99.1 2 d187429dex991.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $175 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – August 26, 2021 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has e
August 26, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 25, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 20, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JULY 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
August 18, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 18, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
August 18, 2021	EX-99.1	Synopsys Posts Financial Results for Third Quarter Fiscal Year 2021 EX-99.1 2 d219157dex991.htm EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Third Quarter Fiscal Year 2021 Q3 2021 Financial Highlights • Revenue: $1,057.1 million • GAAP earnings per share: $1.27 • Non-GAAP ea
June 24, 2021	EX-99.1	Synopsys Initiates $175 Million Accelerated Share Repurchase Agreement Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $175 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. ? June 24, 2021 ? Synopsys, Inc. (Nasdaq: SNPS) today announced that it has entered into an accelerated share repu
June 24, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 23, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (
June 17, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 17, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (
June 17, 2021	EX-99.1	Synopsys Replenishes Repurchase Authorization up to $500 Million EX-99.1 2 d142205dex991.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Replenishes Repurchase Authorization up to $500 Million MOUNTAIN VIEW, Calif. – June 17, 2021 – Synopsys, Inc. (Nasdaq: SNPS) today announced that its Board of Dir
May 28, 2021	EX-1.01	Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 Synopsys, Inc. Conflict Minerals Report For The Year Ended December 31, 2020 Synopsys, Inc. (referred to as “Synopsys,” “we,” “us,” and “our” in this report) has submitted this Conflict Minerals Report for the year ended December 31, 2020 in order to comply with Rule 13p-1 under the Securities Exchange Act, as amended. Rule 13p-1 was adopted by the Securities and Exchange Commission (
May 28, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 690 East Middlefield Road Mountain View, California 94043 (Address of principal execu
May 21, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSYS,
May 21, 2021	EX-10.2	Relocation Assistance Agreement, dated April 30, 2021, by and between Synopsys, Inc. and Sassine Ghazi EX-10.2 2 ex102043021.htm EX-10.2 Exhibit 10.2 RELOCATION ASSISTANCE AGREEMENT This Relocation Assistance Agreement (the “Agreement”) is made and entered into effective as of April 30, 2021 (the “Effective Date”) by and between Sassine Ghazi (the “Employee”) and Synopsys, Inc., a Delaware corporation (the “Company”). R E C I T A L S A. The Employee is and has been employed by the Company and is cu
May 21, 2021	S-8	As filed with the Securities and Exchange Commission on May 21, 2021 As filed with the Securities and Exchange Commission on May 21, 2021 Registration No.
May 19, 2021	EX-99.1	Synopsys Posts Financial Results for Second Quarter Fiscal Year 2021 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for Second Quarter Fiscal Year 2021 Q2 2021 Financial Highlights • Revenue: $1,024.3 million • GAAP earnings per share: $1.24 • Non-GAAP earnings per share: $1.70 MOUNTAIN VI
May 19, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (I
May 3, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 30, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number)
April 12, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 8, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (
April 12, 2021	EX-10.4	2006 Employee Equity Incentive Plan, as amended EX-10.4 2 d120665dex104.htm EX-10.4 Exhibit 10.4 SYNOPSYS, INC. 2006 EMPLOYEE EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 3, 2006 APPROVED BY THE STOCKHOLDERS: APRIL 25, 2006 AS AMENDED BY THE BOARD OF DIRECTORS: JANUARY 19, 2021 AMENDMENT APPROVED BY THE STOCKHOLDERS: APRIL 8, 2021 TERMINATION DATE: APRIL 1, 2026 1. GENERAL. (a) Eligible Award Recipients. The persons eligible t
April 5, 2021	EX-99.1	Synopsys Initiates $100 Million Accelerated Share Repurchase Agreement EX-99.1 2 d114034dex991.htm EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Initiates $100 Million Accelerated Share Repurchase Agreement MOUNTAIN VIEW, Calif. – Apr. 5, 2021 – Synopsys, Inc. (Nasdaq: SNPS) today announced that it has ent
April 5, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 1, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number) (
April 1, 2021	DEFA14A	- DEFA14A DEFA14A 1 d110100ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
February 25, 2021	PX14A6G	- PX14A6G 1 j225210px14a6g.htm Synopsys, Inc. (SNPS) Shareholder Alert Voluntary submission by John Chevedden, POB 2673 , Redondo Beach, CA 90278. Important Information on Proposal 5 – Special Shareholder Meeting Proposal Important Preview for the 2021 Annual Meeting Season At dozens of companies shareholders will vote on 2021 shareholder proposals to give shareholders the right to call a special sh
February 19, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-19807 SYNOPSY
February 18, 2021	DEFA14A	- DEFA14A DEFA14A 1 a2021proxystatement-addlma.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commissio
February 18, 2021	DEF 14A	- DEF 14A DEF 14A 1 a2021proxystatementdef14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission
February 17, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 17, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Numbe
February 17, 2021	EX-99.1	Synopsys Posts Financial Results for First Quarter Fiscal Year 2021 EX-99.1 2 d142579dex991.htm EX-99.1 Exhibit 99.1 PRESS RELEASE INVESTOR CONTACT: Lisa L. Ewbank Synopsys, Inc. 650-584-1901 [email protected] EDITORIAL CONTACT: Simone Souza Synopsys, Inc. 650-584-6454 [email protected] Synopsys Posts Financial Results for First Quarter Fiscal Year 2021 Q1 2021 Financial Highlights • Revenue: $970.3 million • GAAP earnings per share: $1.03 • Non-GAAP earn
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Synopsys Inc. Title of Class of Securities: Common Stock CUSIP Number: 871607107 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
February 9, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 8, 2021 SYNOPSYS, INC. (Exact name of Registrant as specified in charter) Delaware 000-19807 56-1546236 (State or other jurisdiction of incorporation) (Commission File Number

MX:SNPS
DE:SYP	€516.90
IT:1SNPS	€523.20
GB:SYPD
GB:0LBP	$604.69
AT:SYNP

SNPS / Synopsys, Inc. - SEC Filings, Annual Report, Proxy Statement

Basic Stats

SEC Filings

SEC Filings (Chronological Order)

Other Listings